Abstract:Objective To discuss the effect of transarterial chemoembolization(TACE)in the treatment of patients with hepatocellular carcinoma.Methods A total of 60 patients with hepatocellular carcinoma admitted to our hospital from April 2014 to October 2016 were selected as the research objects.They were divided into the control group and the observation group according to the different treatment methods,30 cases in each group.The control group was treated with Fluorouracil and TACE,while the observation group was treated with Gemcitabine plus Cisplatin and TACE,and the index changes of the two groups were compared.Results The total effective rate of the observation group in one year after treatment was 93.33%,which was higher than that of the control group (73.33%),and the difference was statistically significant(P<0.05).There were no significant differences in levels of serum vascular endothelial growth factor(VEGF),tissue growth factor(CTGF),soluble interleukin-2R(sIL-2R),hypoxia inducible factor-2α (HIF-2α)between the observation group and the control group before treatment(P>0.05).The levels of serum VEGF,CTGF,sIL-2R and HIF-2α in the two groups after treatment were significantly different from those before treatment(P<0.05).The levels of serum VEGF,CTGF,sIL-2R and HIF-2α in the observation group after treatment were lower than those in the control group,and the differences were statistically significant(P<0.05).The 2-year survival rate in the observation group was 63.33%,which was higher than 36.67%in the control group,and the difference was statistically significant(P<0.05).The incidence rate of adverse reactions was 13.33%in the observation group and 16.67%in the control group,there was no significant difference between the two groups(P>0.05).Conclusion Gemcitabine combined with Cisplatin via TACE has obvious curative effect on patients with hepatocellular carcinoma,without increasing toxicity and side effects.It has important promotion and application value.
赵强德;汪娇龙;李春燕. 吉西他滨联合顺铂经肝动脉栓塞化疗治疗肝癌患者的效果[J]. 中国当代医药, 2019, 26(5): 74-76.
ZHAO Qiang-de;WANG Jiao-long;LI Chun-yan. Effect of Gemcitabine combined with Cisplatin transarterial chemoembolization in the treatment of patients with hepatocellular carcinoma. 中国当代医药, 2019, 26(5): 74-76.